(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Scholar Rock Holding's revenue in 2026 is $0.On average, 19 Wall Street analysts forecast SRRK's revenue for 2026 to be $957,188,764, with the lowest SRRK revenue forecast at $237,260,109, and the highest SRRK revenue forecast at $2,768,034,608. On average, 19 Wall Street analysts forecast SRRK's revenue for 2027 to be $18,737,557,213, with the lowest SRRK revenue forecast at $8,807,382,843, and the highest SRRK revenue forecast at $26,734,900,491.
In 2028, SRRK is forecast to generate $44,838,565,796 in revenue, with the lowest revenue forecast at $26,187,284,987 and the highest revenue forecast at $63,526,993,391.